Registration
REGISTER FOR THE CONFERENCE
Apply to Exhibit
APPLICATION FOR EXHIBITION
Sponsorship
SPONSORSHIP APPLICATION
Slovakia to Seek Seat on IAEA Board of Governors
Slovakia will seek a seat on the Board of Governors of the International Atomic Energy Agency (IAEA) during the Agency's General Conference in Vienna in September. The Slovak delegation will be led by Foreign Minister Juraj Blanár. Blanár stated that Slovakia is highly dependent on nuclear energy, and securing a seat on the Board would help the country play a greater role in decision-making related to nuclear safety and energy security. Slovakia also plans to use this opportunity to promote innovative nuclear technology applications, including small modular reactors, and to continue strengthening international cooperation in the peaceful uses of nuclear energy. If elected, the Chair of the Slovak Nuclear Regulatory Authority, Marta Žiaková, is expected to represent Slovakia at relevant IAEA Board of Governors meetings.
2026-08-23
Large Transformer Arrives for Restart Project at US Three Mile Island Unit 1
2026-08-23
Gujarat seeks to attract small modular reactor manufacturing projects
2026-08-23
IAEA Upgrades Global Nuclear Power Reactor Database
2026-08-23
Kalinin NPP Participates in Development of Udomlya Master Plan
2026-08-23
Russia's Novovoronezh NPP Publishes 2025 Environmental Safety Report
2026-08-23
Ghana Acquires Nuclear Power Plant Simulator to Advance Nuclear Talent Training
2026-08-23
Six nuclear power units in operation in Ukraine, three under planned maintenance
2026-08-23
Restart Plan for Unit 3 of Japan's Tomari Nuclear Power Plant May Face Uncertainty Due to Supplementary Review and Accident
2026-08-23
Indiana University Health is establishing a new Center of Excellence in Theranostics, planning to provide cancer patients with more personalized diagnostic and treatment services through theranostic technologies. The project combines advanced medical imaging, precision diagnostics, and image-guided targeted therapy, aiming to enhance access to relevant medical services for patients in Indiana. Partial funding comes from a $20 million donor contribution, with Indiana University providing matching funds to bring total donations to $40 million. According to Indiana University, theranostics is a technological approach that integrates diagnosis and treatment. Clinically, advanced imaging techniques are first used...
2026-08-23
A market research report shows that the global Positron Emission Tomography (PET) market size is expected to increase from $1.86 billion in 2025 to $2.81 billion by 2035, with a compound annual growth rate (CAGR) of 4.26% from 2026 to 2035. Increased demand for cancer diagnosis, expanded application of hybrid imaging technologies such as PET-CT and PET-MRI, and continued development of molecular imaging technologies are considered major factors driving market growth. The report notes that PET scans are being increasingly used in scenarios such as cancer detection and treatment evaluation, cardiac disease assessment, and diagnosis of neurological and psychiatric disorders. Meanwhile, population aging, rising healthcare expenditures, and growing demand for early screening are also driving...
2026-08-23
On August 22, the groundbreaking ceremony for the Hengyang New Radiopharmaceutical Isotope and Drug Industrialization Project was held in Hengyang, Hunan Province. Officials from Hengyang City and Zhuhui District, representatives from relevant colleges of the University of South China, investment institutions, and relevant personnel from New Radiopharmaceutical Medical attended the event. Cai Jiming, Chairman and President of New Radiopharmaceutical Medical, stated at the ceremony that the project's landing in Hengyang represents an important strategic layout for the company's nuclear medicine business. From contract signing to construction commencement, the project has received support from local governments, partners, and relevant organizations. The company will leverage this project as an opportunity to continue advancing the transformation of innovative achievements in the fields of medical isotopes and radiopharmaceuticals. Wang Jing, Deputy Mayor of Hengyang City, stated that Hengyang...
2026-08-22
Molecular imaging technology company Cubresa Inc. announced on August 20 that its Cubresa BrainPET™ scanner has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). According to the company, the Cubresa BrainPET™ is a positron emission tomography (PET) device specifically designed for brain imaging and can be integrated into existing Siemens Biograph mMR MR/PET systems. The device enables healthcare institutions to perform simultaneous PET/MR brain imaging on existing MRI infrastructure, capturing molecular and anatomical information without the need to purchase a separate whole-body hybrid imaging system. Cubresa founder and CEO James ...
2026-08-22
On August 20, the customs authorities of the Kaliningrad region of Russia, together with the equipment manufacturer, conducted functional tests of the portal inspection and screening system at the Chernyshevskoye border crossing on the Russia-Lithuania border, focusing on verifying equipment operational status and vehicle inspection capabilities. According to reports, among all Russian border crossings in the Kaliningrad region, only the Chernyshevskoye international road crossing is currently equipped with portal inspection and screening devices. A total of two systems have been installed at this crossing, used respectively for inspecting vehicles entering Russia and those departing, with both units installed and put into operation in December 2025. The inspection and demonstration were carried out with the participation of government regulatory authorities and supplier representatives. The relevant equipment is planned to be...
2026-08-22
The research team at Asan Medical Center in Seoul announced on the 21st that it has recently been selected for the "2026 Korea-U.S. Innovative Outcomes R&D New Support Project" organized by the Ministry of Health and Welfare, and will collaborate with U.S. research institutions to develop an artificial intelligence-based radiopharmaceutical therapy platform aimed at exploring new treatment strategies for solid tumors that respond poorly to conventional therapies. The team is composed of professors including Myung Seung-jae from the Department of Gastroenterology, Oh Seung-jun from the Department of Nuclear Medicine, Ryu Chang-hoon from the Department of Oncology, Jung Byung-kwan from the Department of Pathology, and Son Byung-ho from the Department of Breast Surgery at Asan Medical Center. The project will combine Asan Medical Center's large-scale clinical and pathological data, Emory University's AI-based digital pathology analysis technology, and Case Western Reserve University and University Hospitals Cleveland Medical Center's pathological and clinical research capabilities.
2026-08-22
In 1984, researchers at Texas A&M University used radiation mutagenesis to develop the Rio Red grapefruit. Forty-two years later, this variety has become the dominant cultivar in Texas's grapefruit industry, accounting for approximately 75% of the state's total grapefruit production. The Rio Red grapefruit is distinguished by its vibrant pink flesh, as well as its greater cold tolerance and higher yields compared to other grapefruit varieties. These traits have facilitated its widespread adoption across Texas growing regions, gradually establishing it as a representative grapefruit variety in the local market. Grapefruit itself was not originally a product of artificial breeding. The earliest known grapefruit seedlings appeared in Barbados in the 18th century, resulting from a cross between the Jamaican sweet...
2026-08-22
